• Levpiram is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
• Levpiram is indicated as adjunctive therapy

+ In the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 4 years of age with epilepsy.

+ In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.

+ In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 6 years of age with Idiopathic Generalised Epilepsy.